US Stock MarketDetailed Quotes
SNOA Sonoma Pharmaceuticals
- 2.8000
- -0.1200-4.11%
Close Nov 8 16:00 ET
- 2.8000
- 0.00000.00%
Post 17:16 ET
3.75MMarket Cap-2828P/E (TTM)
3.0000High2.7600Low21.42KVolume2.9300Open2.9200Pre Close61.29KTurnover1.63%Turnover RatioLossP/E (Static)1.34MShares9.374052wk High0.70P/B3.69MFloat Cap2.520052wk Low--Dividend TTM1.32MShs Float72323.1863Historical High--Div YieldTTM8.22%Amplitude2.3180Historical Low2.8610Avg Price1Lot Size
Sonoma Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.05%3.39M | -4.05%12.74M | 14.10%3.44M | 6.59%3.14M | -18.01%2.73M | -13.96%3.43M | 5.10%13.27M | 31.16%3.01M | 1.45%2.94M | -11.03%3.33M |
| Operating revenue | -1.05%3.39M | -4.05%12.74M | 14.10%3.44M | 6.59%3.14M | -18.01%2.73M | -13.96%3.43M | 5.10%13.27M | 31.16%3.01M | 1.45%2.94M | -11.03%3.33M |
| Cost of revenue | -6.21%2.09M | -9.15%7.99M | 9.21%2.35M | -20.59%1.68M | -3.01%1.74M | -4.88%2.22M | 1.85%8.8M | -2.36%2.15M | 24.37%2.11M | -28.29%1.8M |
| Gross profit | 8.47%1.31M | 5.99%4.75M | 26.27%1.09M | 75.69%1.46M | -35.55%990K | -26.85%1.2M | 12.12%4.48M | 800.00%864K | -30.92%831K | 23.77%1.54M |
| Operating expense | 1.43%2.48M | 4.41%9.45M | 24.32%2.5M | -13.55%2.3M | -3.04%2.2M | -2.28%2.44M | -8.43%9.05M | -36.28%2.01M | 23.32%2.67M | 2.81%2.27M |
| Selling and administrative expenses | -5.19%2.01M | -14.31%7.58M | 15.52%2.09M | -36.10%1.7M | -19.59%1.66M | -7.67%2.12M | -9.38%8.84M | -42.58%1.81M | 24.82%2.67M | -5.83%2.07M |
| Research and development costs | 44.62%470K | 803.86%1.87M | 103.48%409K | --601K | 168.00%536K | 57.77%325K | 65.60%207K | 4,925.00%201K | --0 | 1,900.00%200K |
| Operating profit | 5.40%-1.17M | -2.87%-4.7M | -22.84%-1.41M | 53.98%-844K | -65.25%-1.21M | -45.03%-1.24M | 22.37%-4.57M | 62.52%-1.15M | -91.44%-1.83M | 24.17%-731K |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 183.41%176K | 46.25%-330K | 117.12%50K | -11.27%-79K | 51.61%-90K | -214.93%-211K | -228.18%-614K | -37.09%-292K | -745.45%-71K | -121.31%-186K |
| Other non- operating income (expenses) | 183.41%176K | 46.25%-330K | 117.12%50K | -11.27%-79K | 51.61%-90K | -214.93%-211K | -55.84%-614K | 68.80%-292K | -745.45%-71K | -125.73%-186K |
| Income before tax | 31.29%-997K | 2.95%-5.03M | 5.56%-1.36M | 51.55%-923K | -41.55%-1.3M | -57.38%-1.45M | 4.32%-5.18M | 56.15%-1.44M | -101.80%-1.91M | -865.26%-917K |
| Income tax | 542.42%146K | -493.94%-196K | -122.90%-292K | -267.65%-57K | 86.00%186K | 5.71%-33K | 90.06%-33K | 61.24%-131K | 34K | 1,900.00%100K |
| Net income | 19.39%-1.14M | 6.13%-4.84M | 18.43%-1.07M | 55.34%-866K | -45.92%-1.48M | -59.86%-1.42M | -1.28%-5.15M | 55.57%-1.31M | -105.40%-1.94M | -917.00%-1.02M |
| Net income continuous Operations | 19.39%-1.14M | 6.13%-4.84M | 18.43%-1.07M | 55.34%-866K | -45.92%-1.48M | -59.86%-1.42M | -1.28%-5.15M | 55.57%-1.31M | -105.40%-1.94M | -917.00%-1.02M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.39%-1.14M | 6.13%-4.84M | 18.43%-1.07M | 55.34%-866K | -45.92%-1.48M | -59.86%-1.42M | -1.28%-5.15M | 55.57%-1.31M | -105.40%-1.94M | -917.00%-1.02M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.39%-1.14M | 6.13%-4.84M | 18.43%-1.07M | 55.34%-866K | -45.92%-1.48M | -59.86%-1.42M | -1.28%-5.15M | 55.57%-1.31M | -105.40%-1.94M | -917.00%-1.02M |
| Basic earnings per share | 75.86%-1.4 | 65.13%-10.6 | 75.58%-1.3673 | 87.10%-1.6 | 12.12%-5.8 | 0.00%-5.8 | 20.83%-30.4 | 73.83%-5.6 | -100.00%-12.4 | -725.00%-6.6 |
| Diluted earnings per share | 75.86%-1.4 | 65.13%-10.6 | 75.58%-1.3673 | 87.10%-1.6 | 12.12%-5.8 | 0.00%-5.8 | 20.83%-30.4 | 73.83%-5.6 | -100.00%-12.4 | -725.00%-6.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
